Article

Unique Combinations of epigenetic modifiers synergistically impair the viability of the U87 glioblastoma cell line while exhibiting minor or moderate effects on normal stem cell growth

2021-11-23

Abstract excerpt

<title>Abstract</title> <p>Discoveries made over the last decade have shown that critical changes in cancer cells, such as activation of oncogenes and silencing of tumor suppressor genes are caused not only by genetic but also by epigenetic mechanisms. While epigenetic alterations are somatically heritable, in contrast to genetic changes, they are potentially reversible, making them perfect targets for therapeuti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dbe6bba8-35cf-5101-ac7a-aa21e2a70150
DOI: 10.21203/rs.3.rs-1072015/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Unique Combinations of epigenetic modifiers synergistically impair the viability of the U87 glioblastoma cell line while exhibiting minor or moderate effects on normal stem cell growthDOI 10.21203/rs.3.rs-1072015/v1Read

Advances in epigenetic glioblastoma therapySemantic proximity Read

Pre-treatment or Post-treatment of Human Glioma Cells With BIX01294, the Inhibitor of Histone Methyltransferase G9a, Sensitizes Cells to TemozolomideSemantic proximity Read

Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cellsSemantic proximity Read

Combining EZH2 inhibitors with other therapies for solid tumors: more choices for better effectsSemantic proximity Read

PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomideSemantic proximity Read

Histone deacetylase inhibitors in cancer therapy. A reviewSemantic proximity Read

HDAC Inhibitor Vorinostat and BET Inhibitor Plx51107 Epigenetic Agents’ Combined Treatments Exert a Therapeutic Approach Upon Acute Myeloid Leukemia Cell ModelSemantic proximity Read

Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cellsSemantic proximity Read

Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cellsSemantic proximity Read

CPI203, a BET inhibitor, down-regulates a consistent set of DNA synthesis genes across a wide array of glioblastoma linesSemantic proximity Read

Clinical potential of histone deacetylase inhibitors as stand alone therapeutics and in combination with other chemotherapeutics or radiotherapy for cancer.Semantic proximity Read

Understanding the Mechanisms by Which Epigenetic Modifiers Avert Therapy Resistance in CancerSemantic proximity Read